Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eckhard R Podack

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Hematology/Oncology Clinics of North America|June 10, 2006
Heat shock protein-based cancer vaccinesKelvin P Lee, Luis E Raez, Eckhard R Podack
Immunologic Research|December 3, 2013
B cell regulation of anti-tumor immune responseYu Zhang, Richard Morgan, Eckhard R Podack, et al.
Antiviral Research|August 5, 2003
Murine cytomegalovirus retinitis during retrovirus-induced immunodeficiency (MAIDS) in mice: interleukin-2 immunotherapy correlates with increased intraocular levels of perforin mRNARichard D Dix, Eckhard R Podack, Scott W Cousins
Immunologic Research|December 3, 2013
Killing machines: three pore-forming proteins of the immune systemRyan McCormack, Lesley de Armas, Motoaki Shiratsuchi, et al.
Immunity|March 22, 2003
Perforin is required for innate and adaptive immunity induced by heat shock protein gp96Natasa Strbo, Satoshi Oizumi, Vlatka Sotosek-Tokmadzic, et al.
Seminars in Immunology|March 16, 2010
Tumor immunogenicity and responsiveness to cancer vaccine therapy: the state of the artTaylor H Schreiber, Luis Raez, Joseph D Rosenblatt, et al.
Transplantation|April 13, 2004
Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipientsLianne Marks, Norman H Altman, Eckhard R Podack, et al.
Expert Review of Anticancer Therapy|August 23, 2005
Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccinesLuis E Raez, Edgardo S Santos, Raja Mudad, et al.
Immunologic Research|November 21, 2013
Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseasesNatasa Strbo, Arlene Garcia-Soto, Taylor H Schreiber, et al.
Leukemia & Lymphoma|May 31, 2011
CD30: an important new target in hematologic malignanciesYehuda E Deutsch, Tamar Tadmor, Eckhard R Podack, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Hematology/Oncology Clinics of North America|June 10, 2006
Heat shock protein-based cancer vaccinesKelvin P Lee, Luis E Raez, Eckhard R Podack
Immunologic Research|December 3, 2013
B cell regulation of anti-tumor immune responseYu Zhang, Richard Morgan, Eckhard R Podack, et al.
Antiviral Research|August 5, 2003
Murine cytomegalovirus retinitis during retrovirus-induced immunodeficiency (MAIDS) in mice: interleukin-2 immunotherapy correlates with increased intraocular levels of perforin mRNARichard D Dix, Eckhard R Podack, Scott W Cousins
Immunologic Research|December 3, 2013
Killing machines: three pore-forming proteins of the immune systemRyan McCormack, Lesley de Armas, Motoaki Shiratsuchi, et al.
Immunity|March 22, 2003
Perforin is required for innate and adaptive immunity induced by heat shock protein gp96Natasa Strbo, Satoshi Oizumi, Vlatka Sotosek-Tokmadzic, et al.
Seminars in Immunology|March 16, 2010
Tumor immunogenicity and responsiveness to cancer vaccine therapy: the state of the artTaylor H Schreiber, Luis Raez, Joseph D Rosenblatt, et al.
Transplantation|April 13, 2004
Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipientsLianne Marks, Norman H Altman, Eckhard R Podack, et al.
Expert Review of Anticancer Therapy|August 23, 2005
Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccinesLuis E Raez, Edgardo S Santos, Raja Mudad, et al.
Immunologic Research|November 21, 2013
Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseasesNatasa Strbo, Arlene Garcia-Soto, Taylor H Schreiber, et al.
Leukemia & Lymphoma|May 31, 2011
CD30: an important new target in hematologic malignanciesYehuda E Deutsch, Tamar Tadmor, Eckhard R Podack, et al.
Pageof 9